LBA Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$10K Hold
134
0.01% 330
2016
Q4
$8K Hold
134
﹤0.01% 340
2016
Q3
$9K Hold
134
0.01% 332
2016
Q2
$8K Hold
134
﹤0.01% 321
2016
Q1
$8K Hold
134
﹤0.01% 319
2015
Q4
$7K Hold
134
﹤0.01% 319
2015
Q3
$7K Hold
134
﹤0.01% 273
2015
Q2
$8K Hold
134
0.01% 256
2015
Q1
$10K Hold
134
0.01% 240
2014
Q4
$8K Hold
134
0.01% 239
2014
Q3
$7K Hold
134
﹤0.01% 305
2014
Q2
$7K Hold
134
0.01% 220
2014
Q1
$6K Hold
134
﹤0.01% 221
2013
Q4
$6K Buy
+134
New +$6.78K ﹤0.01% 238

Other funds holding RMD

LBA Wealth Management's RMD Position: Q1 2017 in Review

LBA Wealth Management held its ResMed (RMD) position steady in Q1 2017 at 134 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #330.

LBA Wealth Management first reported a position in RMD in Q4 2013 and has held it in 14 quarters since. 374 funds tracked by Wall St. Rank hold RMD as of Q1 2017.

  • LBA Wealth Management held 134 shares of ResMed worth $10K as of Q1 2017.
  • LBA Wealth Management left its ResMed share count unchanged in Q1 2017.
  • ResMed made up 0.01% of LBA Wealth Management's portfolio in Q1 2017, its #330 holding.
  • LBA Wealth Management first reported a position in ResMed in Q4 2013 and has held it in 14 quarters since.
  • 374 funds tracked by Wall St. Rank held ResMed as of Q1 2017.

Based on LBA Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.